UK research highlights need to tackle HCV (hepatitis C virus) prevalence
This article was originally published in Clinica
Population screening for hepatitis C virus (HCV) should be introduced, say researchers studying the prevalence of the disease among pregnant women in the UK.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.